All Clinical Trials in Canada

A listing of 3913 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

Canada

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Intensive Cancer Screening After Cryptogenic Stroke

NCT05733416

Recruiting

The INCOGNITO Pilot Trial is a single centre pilot prospective randomized open-label blinded endpoint (PROBE) trial to assess the feasibility of a full-scale randomized trial to determine whether an occult cancer screening strategy of FDG PET/CT (F-fluorodeoxyglucose positron emission/computed tomography) in addition to usual care increases the number of occult cancers diagnosed after screening compared to usual care cancer screening alone in patients with cryptogenic stroke.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/29/2025

Locations: The Ottawa Hospital, Ottawa, Ontario

Conditions: Occult Cancer

Learn More ›

Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

NCT06608927

Recruiting

The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitabine in all randomized patients.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/29/2025

Locations: Mayo Clinic Arizona - Phoenix Campus, Phoenix, Arizona +132 locations

Mayo Clinic Arizona - Phoenix Campus, Phoenix, Arizona

University of Arizona Cancer Center, Tucson, Arizona

University of California San Diego Health, La Jolla, California

Cancer & Blood Specialty Clinic - Los Alamitos, Los Alamitos, California

Keck Medicine of USC - Keck Hospital of USC, Los Angeles, California

Sutter Medical Center, Roseville, California

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California

UCLA Health - Santa Monica Cancer Care, Santa Monica, California

UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora, Colorado

USOR - Rocky Mountain Cancer Centers - Denver - Midtown, Denver, Colorado

Yale Cancer Center, New Haven, Connecticut

Mayo Clinic - Jacksonville, Jacksonville, Florida

Miami Cancer Institute, Miami, Florida

Piedmont Cancer Institute, Atlanta, Georgia

Emory University Hospital, Atlanta, Georgia

USOR - Illinois Cancer Specialists - Arlington Heights, Arlington Heights, Illinois

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois

University of Chicago, Chicago, Illinois

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana

Cancer Center of Kansas - Medical Arts Tower, Wichita, Kansas

Mary Bird Perkins Cancer Center - Baton Rouge, Baton Rouge, Louisiana

Maine Medical Center, Portland, Maine

University of Michigan Rogel Cancer Center, Ann Arbor, Michigan

Cancer & Hematology Centers of Western Michigan - Lemmen-Holton Cancer Pavilion, Grand Rapids, Michigan

HealthPartners Cancer Research Center - Cancer Center at Regions Hospital, Minneapolis, Minnesota

Mayo Clinic - Rochester, Rochester, Minnesota

MediSync Clinical Research - Hattiesburg Clinic, Hattiesburg, Mississippi

Saint Luke's Hospital of Kansas City, Kansas City, Missouri

University of Nebraska Medical Center, Omaha, Nebraska

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey

University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico

Roswell Park Comprehensive Cancer Center, Buffalo, New York

Clinical Research Alliance, New Hyde Park, New York

New York University Medical Oncology Associates, New York, New York

Columbia University Irving Medical Center - Herbert Irving Pavilion, New York, New York

Memorial Sloan-Kettering Cancer Center - New York - Rockefeller Outpatient Pavilion, New York, New York

Mount Sinai Medical Center Comprehensive Cancer Center, New York, New York

James P. Wilmot Cancer Center, Rochester, New York

University Hospitals Cleveland Medical Center, Cleveland, Ohio

Stephenson Cancer Center, Oklahoma City, Oklahoma

Fox Chase Cancer Center, Philadelphia, Pennsylvania

University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, Pennsylvania

SCRI Oncology Partners, Nashville, Tennessee

Vanderbilt University Medical Center, Nashville, Tennessee

USOR - Texas Oncology - Austin Midtown, Austin, Texas

USOR - Texas Oncology - Dallas Fort Worth (DFW) - Baylor Charles A. Sammons Cancer Center, Dallas, Texas

University of Texas Southwestern Medical Center, Dallas, Texas

University of Texas MD Anderson Cancer Center, Houston, Texas

USOR - Texas Oncology - San Antonio Medical Center, San Antonio, Texas

USOR - Texas Oncology - Deke Slayton Cancer Center, Webster, Texas

Inova Medical Group - Hematology Oncology - Arlington, Fairfax, Virginia

Virginia Mason Medical Center, Seattle, Washington

Summit Cancer Centers - Spokane Valley, Spokane, Washington

USOR - Northwest Cancer Specialists, P.C. dba Compass Oncology - Vancouver Cancer Center, Vancouver, Washington

University of Wisconsin - Madison, Madison, Wisconsin

Chris O'Brien Lifehouse, Camperdown, Not set

Monash Health, Clayton, Not set

Oncology West - Murdoch, Murdoch, Not set

Wollongong Hospital, Wollongong, Not set

Salzburg Cancer Research Institute, Salzburg, Not set

Universitätsklinikum Sankt Pölten, Sankt Pölten, Not set

Krankenhaus Der Barmherzigen Brüder Wien, Wien, Not set

Medizinische Universität Wien, Wien, Not set

Institut Jules Bordet, Anderlecht, Not set

Imeldaziekenhuis, Bonheiden, Not set

Algemeen Ziekenhuis Groeninge - Campus Kennedylaan, Kortrijk, Not set

Ottawa Hospital - General Campus, Ottawa, Not set

Hôtel-Dieu de Sherbrooke, Sherbrooke, Not set

Princess Margaret Cancer Centre, Toronto, Not set

Sunnybrook Health Sciences Centre - Bayview Campus, Toronto, Not set

Nemocnice AGEL Nový Jičín a.s., Nový Jičín, Not set

Fakultni nemocnice v Motole, Praha, Not set

Centre Georges François Leclerc, Dijon cedex, Not set

Hôpital Huriez, Lille Cedex, Not set

Centre Léon Bérard, Lyon, Not set

Centre Hospitalier Universitaire de Poitiers, Poitiers, Not set

Gustave Roussy, Villejuif, Not set

Katholisches Klinikum Bochum - St. Josef-Hospital, Bochum, Not set

Universitatsklinikum Carl Gustav Carus Dresden, Dresden, Not set

Universitätsklinikum Düsseldorf, Düsseldorf, Not set

Krankenhaus Nordwest, Frankfurt am Main, Not set

Asklepios Klinik Altona, Hamburg, Not set

Facharztzentrum Eppendorf, Hamburg, Not set

Katholisches Marienkrankenhaus, Hamburg, Not set

Medizinische Hochschule Hannover, Hannover, Not set

SLK-Kliniken Heilbronn - Klinikum am Gesundbrunnen, Heilbronn, Not set

Elblandklinikum Riesa, Riesa, Not set

Universitätsklinikum Ulm, Ulm, Not set

Universitätsklinikum Würzburg, Wuerzburg, Not set

Azienda Ospedaliero-Universitaria di Bologna - Policlinico Sant Orsola-Malpighi, Bologna, Not set

Ospedale di Cremona, Cremona, Not set

Azienda Ospedaliero - Universitaria Careggi, Firenze, Not set

Fondazione IRCCS - Istituto Nazionale dei Tumori, Milano, Not set

Istituto Europeo di Oncologia, Milano, Not set

Azienda Ospedaliero - Universitaria di Modena, Modena, Not set

Istituto Oncologico Veneto - IRCCS, Padova, Not set

Ospedale Guglielmo da Saliceto, Piacenza, Not set

IRCCS Istituto Nazionale Tumori Regina Elena, Roma, Not set

Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Istituto Clinico Humanitas, Rozzano, Not set

Azienda Ospedaliero Universitaria Delle Marche, Torrette, Not set

Azienda Ospedaliera Universitaria Integrata Verona, Verona, Not set

National Cancer Center Hospital East, Kashiwa-shi, Not set

Cancer Institute Hospital of JFCR, Koto, Not set

Osaka Prefectural Hospital Organization - Osaka International Cancer Institute, Osaka, Not set

National Cancer Center Hospital, Tokyo, Not set

Toyama University Hospital, Toyama, Not set

Yamaguchi University Hospital, Ube, Not set

Kanagawa Cancer Center, Yokohama-Shi, Not set

Chonnam National University Hwasun Hospital, Hwasun, Not set

Cha Bundang Medical Center, Seongnam, Not set

Asan Medical Center, Seoul, Not set

Samsung Medical Center, Seoul, Not set

Seoul National University Hospital, Seoul, Not set

Severance Hospital, Seoul, Not set

Hospital Clinic de Barcelona, Barcelona, Not set

Hospital Universitari Vall d'Hebrón, Barcelona, Not set

Hospital General Universitario de Elche, Elche, Not set

Institut Català d'Oncologia Girona (ICO Girona), Girona, Not set

Clínica Universidad de Navarra - Madrid, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario HM Sanchinarro, Madrid, Not set

Hospital Universitario La Paz, Madrid, Not set

Clinica Universidad de Navarra - Pamplona, Pamplona, Not set

Hospital Universitario de Navarra, Pamplona, Not set

Consorci Hospital General Universitari de València, Valencia, Not set

Hospital Alvaro Cunqueiro - Clinico Universitario Vigo, Vigo, Not set

Hospital Universitario Miguel Servet, Zaragoza, Not set

Hull University Teaching Hospitals NHS Trust, Cottingham, Not set

Royal Free London NHS Foundation Trust, London, Not set

Sarah Cannon Research Institute London, London, Not set

University College London Hospitals NHS Foundation Trust, London, Not set

The Christie NHS Foundation Trust, Manchester, Not set

University Hospitals Birmingham NHS Foundation Trust, Oxford, Not set

Conditions: Metastatic Pancreatic Ductal Adenocarcinoma

Learn More ›

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

NCT06618287

Recruiting

The purpose of this study is to evaluate the safety, tolerability, drug levels, and preliminary efficacy of BMS-986507 combinations in adult participants with advanced solid tumors.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/29/2025

Locations: Local Institution - 0066, Birmingham, Alabama +46 locations

Local Institution - 0066, Birmingham, Alabama

University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami, Florida

Local Institution - 0065, Iowa City, Iowa

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey

Cleveland Clinic, Cleveland, Ohio

Local Institution - 0052, Portland, Oregon

Local Institution - 0014, Pittsburgh, Pennsylvania

Swedish Medical Center, Seattle, Washington

Liverpool Hospital, Liverpool, New South Wales

Princess Alexandra Hospital, Woolloongabba, Queensland

Cross Cancer Institute, Edmonton, Alberta

Local Institution - 0064, Newmarket, Ontario

Local Institution - 0023, Ottawa, Ontario

The Ottawa Hospital - General Campus, Ottawa, Ontario

Jewish General Hospital, Montreal, Quebec

Centre Hospitalier de l'Université de Montréal, Montréal, Quebec

Local Institution - 0048, Santiago, Región Metropolitana De Santiago

Local Institution - 0049, Santiago, Región Metropolitana De Santiago

Local Institution - 0047, Santiago, Región Metropolitana De Santiago

Local Institution - 0043, Bordeaux, Aquitaine

Local Institution - 0045, Marseille, Bouches-du-Rhône

Local Institution - 0053, Montpellier, Hérault

Local Institution - 0050, Lyon, Rhône-Alpes

Local Institution - 0041, Villejuif, Val-de-Marne

Local Institution - 0054, Paris, Not set

Local Institution - 0040, Paris, Not set

Local Institution - 0034, Aviano, Friuli-Venezia Giulia

Local Institution - 0033, Milan, Lombardia

Local Institution - 0056, Candiolo, Torino

Local Institution - 0035, Firenze, Toscana

Local Institution - 0032, Roma, Not set

Leids Universitair Medisch Centrum, Leiden, Zuid-Holland

Nederlands Kanker Instituut Antoni van Leeuwenhoek (NKI AVL), Amsterdam, Not set

Local Institution - 0062, Santiago de Compostela, A Coruña [La Coruña]

Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona]

Local Institution - 0058, Hospitalet, Barcelona [Barcelona]

Local Institution - 0059, Barcelona, Catalunya [Cataluña]

Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad De

Local Institution - 0061, Majadahonda, Madrid, Comunidad De

Hospital Universitario Fundación Jiménez Díaz, Madrid, Not set

Hospital Universitario HM Sanchinarro, Madrid, Not set

Local Institution - 0063, Málaga, Not set

Local Institution - 0060, València, Not set

Royal Free Hospital, London, England

Local Institution - 0021, Glasgow, Glasgow City

University Hospitals Birmingham NHS Foundation Trust, Birmingham, West Midlands

Local Institution - 0001, Newcastle upon Tyne, Not set

Conditions: Lung Cancer

Learn More ›

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

NCT04786262

Recruiting

This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia.

Gender:

ALL

Ages:

Between 18 years and 65 years

Trial Updated:

07/29/2025

Locations: City of Hope, Duarte, California +28 locations

City of Hope, Duarte, California

University of California San Francisco, San Francisco, California

UHealth Diabetes Research Institute, Miami, Florida

Northwestern Organ Transplant Center, Chicago, Illinois

University of Chicago, Chicago, Illinois

Johns Hopkins University, Baltimore, Maryland

Massachusetts General Hospital, Boston, Massachusetts

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

University of Pittsburgh Medical Center Montefiore, Pittsburgh, Pennsylvania

Baylor Scott and White Research Institute, Dallas, Texas

VCU Medical Center, Richmond, Richmond, Virginia

University of Wisconsin, Madison, Wisconsin

University of Alberta, Edmonton, Edmonton, Not set

McGill University Health Centre, Montreal, Not set

Toronto General Hospital (TGH), Toronto, Not set

Vancouver General Hospital, Vancouver, Not set

CHU Lille, Lille, Not set

Centre de recherche en Biomédecine de Strasbourg, Strasbourg, Not set

Dresden Center for Islet Transplantation, Dresden, Not set

IRCCS Ospedale San Raffaele, Milan, Not set

Leiden University, Leiden, Not set

Oslo University Hospital, Oslo, Not set

King Abdullah International Medical Research Center (KAIMRC) - Riyadh - Endocrinology, Riyadh, Not set

King Faisal Specialist Hospital & Research Centre - Riyadh - Endocrinology, Riyadh, Not set

Hopiteaux Universitaires de Geneve, Geneve, Not set

Churchill Hospital, Headington, Oxford

Royal Infirmary of Edinburgh, Edinburgh, Not set

Cardiovascular, Metabolic Medicine and Sciences, King's College London, London, Not set

The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, Not set

Conditions: Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia

Learn More ›

A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)

NCT04245839

Recruiting

This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/r FL or MZL. The study will be conducted in compliance with the International Council on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use/Good Clinical Practice (GCP) and applicable regulatory requirements. This study is divided into three periods: * Pretreatment, which consists of screening assessme... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/29/2025

Locations: UCLA Medical Centre-Santa Monica, Santa Monica, California +58 locations

UCLA Medical Centre-Santa Monica, Santa Monica, California

University Of Colorado Cancer Center, Aurora, Colorado

Yale Cancer Center, New Haven, Connecticut

Local Institution - 0601, Hollywood, Florida

Washington University School Of Medicine, Miami, Florida

Northwestern University, Chicago, Illinois

Local Institution - 109, Niles, Illinois

University Of Iowa, Iowa City, Iowa

Cancer Center of Kansas, Wichita, Kansas

University of Maryland - Greenebaum Comprehensive Cancer Center, Baltimore, Maryland

Massachusetts General Hospital - Dana-Farber Cancer Institute, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Karmanos Cancer Center, Detroit, Michigan

Local Institution - 118, Detroit, Michigan

Atlantic Health System Morristown Medical Center, Morristown, New Jersey

Memorial Sloan Kettering Cancer Center, New York, New York

Novant Health Presbyterian Medical Center, Charlotte, North Carolina

Local Institution - 120, Fargo, North Dakota

Cleveland Clinic Foundation, Cleveland, Ohio

Providence Cancer Center/Earle A. Chiles Res. Inst., Portland, Oregon

University of Pennsylvania - Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania

Local Institution - 126, Pittsburgh, Pennsylvania

Local Institution - 113, Sioux Falls, South Dakota

Local Institution - 125, Knoxville, Tennessee

Texas Oncology, Dallas, Texas

Houston Methodist Hospital, Houston, Texas

The University of Texas - MD Anderson Cancer Center, Houston, Texas

University Of Virginia Health System, Charlottesville, Virginia

Fred Hutchinson Cancer Center, Seattle, Washington

Allgemeinen Krankenhaus (AKH) Wien - Medizinische Universitaet Wien, Wien, Not set

Princess Margaret Cancer Centre, Toronto, Ontario

Hopital Maisonneuve - Rosemont, Montreal, Quebec

CHRU-Hopital Claude Huriez, Lille, Not set

CHU Montpellier - Hôpital Saint Eloi, Montpellier CEDEX 5, Not set

Hopital Saint Louis, Paris Cedex 10, Not set

Centre Hospitalier Lyon-Sud, Pierre-Benite CEDEX, Not set

Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou, Rennes Cedex 02, Not set

Institut Universitaire du Cancer Toulouse - Oncopole - CHU de TOULOUSE, Toulouse, Not set

Universitaetsklinikum Ulm, Ulm, Baden-Wurttemberg

Local Institution - 504, Regensburg, Bayern

Local Institution - 506, Berlin, Not set

Local Institution - 503, Karlsruhe, Not set

Local Institution - 505, Kiel, Not set

University Hospital Cologne, Köln, Not set

LMU Klinikum der Universitat Munchen, Munich, Not set

Azienda Ospedaliera Papa Giovanni Xxiii, Bergamo, Not set

Local Institution - 302, Bologna, Not set

Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale, Naples, Not set

Local Institution - 553, Sapporo-shi, Hokkaido

Local Institution - 550, Chuo-ku, Tokyo

Local Institution - 551, Minato-ku, Tokyo

Local Institution - 552, Fukuoka, Not set

Local Institution - 352, Barcelona, Not set

Hospital General Universitario Gregorio Marañon, Madrid, Not set

Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca, Salamanca, Not set

Hospital Virgen Del Rocio, Sevilla, Not set

Karolinska Hospital, Stockholm, Not set

University College London Hospitals NHS Foundation Trust - University College Hospital, London, Not set

The Christie NHS Foundation Trust, Manchester, Not set

Conditions: Lymphoma, Non-Hodgkin

Learn More ›

Trifecta-Heart cfDNA-MMDx Study

NCT04707872

Recruiting

Demonstrate the relationship between DD-cfDNA levels and HLA antibodies in blood transplant recipient and the Molecular Microscope® (MMDx) Diagnostic System results in indication and protocol biopsies from heart transplants.

Gender:

ALL

Ages:

All

Trial Updated:

07/28/2025

Locations: Baptist Health Institute for Research and Innovation, Little Rock, Arkansas +11 locations

Conditions: Heart Transplant Rejection

Learn More ›

Methoxyflurane for IUD Insertion and Endometrial Biopsy

NCT07046572

Recruiting

The aim of this study is to determine if 3ml of inhaled Methoxyflurane, in the form of a Penthrox inhaler, reduces pain during IUD insertion and/or endometrial biopsy. The proposed study is a double-blind, placebo-controlled RCT. Each participant will be randomly assigned to one of two arms: 1. Intervention (3ml of Methoxyflurane via a Penthrox inhaler) 2. Placebo (3ml of normal saline via an identical placebo Penthrox inhaler) The primary outcome is global pain score, which will be patient-r... Read More

Gender:

FEMALE

Ages:

Between 18 years and 65 years

Trial Updated:

07/28/2025

Locations: OPG, Toronto, Ontario

Conditions: Endometrial Biopsy, Intrauterine Devices

Learn More ›

Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

NCT06679881

Recruiting

This is a Phase 3, multicenter, long-term, open-label study to evaluate the safety and efficacy of once-daily orally administered deucrictibant extended-release tablet for prophylaxis to prevent angioedema attacks in participants aged ≥12 years with Hereditary Angioedema

Gender:

ALL

Ages:

12 years and above

Trial Updated:

07/28/2025

Locations: Study Site, Santa Monica, California +16 locations

Conditions: Hereditary Angioedema (HAE)

Learn More ›

Pan-Canadian Lung Cancer Observational Study (PALEOS)

NCT04706754

Recruiting

A multicenter, ambispective observational study focusing on patients diagnosed with lung cancer in Canada identified after January 1, 2000 inclusive. This data will be combined with that from deceased patients identified.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/28/2025

Locations: Milena (Lynn) Vicente, Brampton, Ontario

Conditions: Lung Cancer

Learn More ›

ADVENT Post Approval Study

NCT06431815

Recruiting

The ADVENT Post Approval Study (PAS) is a prospective, global, multicenter, observational study.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/28/2025

Locations: Mobile Infirmary Medical Center, Mobile, Alabama +33 locations

Mobile Infirmary Medical Center, Mobile, Alabama

Scottsdale Healthcare - Shea, Scottsdale, Arizona

Alta Bates Summit Medical Center, Oakland, California

Washington Hospital Center, Washington, District of Columbia

Florida Heart Rhythm Specialists, PLLC, Fort Lauderdale, Florida

Baptist Medical Center, Jacksonville, Florida

Mount Sinai Medical Center, Miami Beach, Florida

Tallahassee Memorial Hospital, Tallahassee, Florida

AdventHealth Tampa, Tampa, Florida

Memorial Health University Medical Center, Savannah, Georgia

Ochsner Clinic Foundation, New Orleans, Louisiana

Beth Israel Deaconess Medical Center, Boston, Massachusetts

University of Mississippi Medical Center, Jackson, Mississippi

Montefiore Medical Center, Bronx, New York

New York Hospital Queens, Flushing, New York

Columbia University Medical Center, New York, New York

Northwell Health, New York, New York

East Carolina University Medical Center, Greenville, North Carolina

Pinnacle Health at Harrisburg Hospital, Harrisburg, Pennsylvania

Medical University of South Carolina, Charleston, South Carolina

Prisma Health Richland Hospital, Columbia, South Carolina

Vanderbilt University Medical Center, Nashville, Tennessee

University of Texas Medical Branch, Galveston, Texas

University of Texas Houston Health Science Center, Houston, Texas

Orion Medical, Houston, Texas

Sentara Norfolk General Hospital, Norfolk, Virginia

University of Washington Medical Center, Seattle, Washington

Sos Cardio Servicoshospitalares Ltda, Florianópolis, Santa Catarina

Instituto do Coração do HCFMUSP, São Paulo, Sao Paulo

Southlake Regional General Hospital, Newmarket, Ontario

Institut de Cardiologie de Montreal-Hospital, Montréal, Quebec

Institut universitaire de Cardiologie et de Pneumologie de Quebec, Québec, Quebec

Hospital Regional de Concepcion, Concepción, Biobio

Fundacion Cardio-Infantil-Hospital, Bogotá, Not set

Conditions: Paroxysmal Atrial Fibrillation

Learn More ›

Cannabidiol After Multi-Trauma for Pain and Opioid Therapy

NCT06448923

Recruiting

The aim of this project is to investigate the therapeutic potential and safety of acute Cannabidiol (CBD) treatment on longitudinal pain symptoms, and to assess potential interactions with pain mediators including opioids and sex on CBD treatment response. To this end, this research protocol proposes a comprehensive translational approach including a placebo-controlled randomized clinical trial comparing two daily doses of CBD treatment administered for one month on pain relief. This study will... Read More

Gender:

ALL

Ages:

Between 18 years and 70 years

Trial Updated:

07/28/2025

Locations: Hôpital Sacré-Coeur de Montréal, Montréal, Quebec

Conditions: Fracture

Learn More ›

A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

NCT05976243

Recruiting

This is a Phase 3, parallel group, placebo-controlled, double-blind, confirmatory study in patients with CINDU, with an optional Open-label Extension (OLE). The purpose of the core period (52 weeks of treatment) of this study is to evaluate the efficacy, safety, and tolerability of remibrutinib (LOU064) vs. placebo in adults suffering from CINDU inadequately controlled by H1-antihistamines (H1-AHs). The purpose of the OLE period is to collect long-term efficacy, safety, and tolerability data o... Read More

Gender:

ALL

Ages:

Between 18 years and 100 years

Trial Updated:

07/28/2025

Locations: Allervie Clinical Research, Birmingham, Alabama +160 locations

Allervie Clinical Research, Birmingham, Alabama

Acuro Research Inc, Little Rock, Arkansas

Kern Research, Bakersfield, California

OC Allergy and Asthma Specialists, Huntington Beach, California

Antelope Valley Clinical Trials, Lancaster, California

Asthma and Allergy Associates P C, Colorado Springs, Colorado

Florida Ctr Allergy Asthma Research, Aventura, Florida

Finlay Medical Research, Greenacres City, Florida

Sarasota Clinical Research, Sarasota, Florida

Univ of South Florida Asthma Allergy and Immunology CRU, Tampa, Florida

AeroAllergy Research Laboratories of Savannah Inc, Savannah, Georgia

Treasure Valley Medical Research, Boise, Idaho

Endeavor Health, Glenview, Illinois

Asthma and Allergy Center of Chicago S C, River Forest, Illinois

The Indiana Clinical Trials Center, Plainfield, Indiana

Allergy and Asthma Specialist P S C, Owensboro, Kentucky

John Hopkins University, Baltimore, Maryland

Somnos Clinical Research, Lincoln, Nebraska

Toledo Institute of Clinical Research, Toledo, Ohio

Allergy Asthma and Clinical Research, Oklahoma City, Oklahoma

Allergy and Clinical Immunology Associates, Pittsburgh, Pennsylvania

National Allergy and Asthma Research LLS, North Charleston, South Carolina

PanAmerican Clinical Research, Brownsville, Texas

Asthma and Allergy Research Assoc, Dallas, Texas

Western Sky Medical Research, El Paso, Texas

RFSA Dermatology, San Antonio, Texas

STAAMP Research LLC, San Antonio, Texas

Complete Dermatology, Sugar Land, Texas

Allergy Associates of Utah, Sandy, Utah

Novartis Investigative Site, Caba, Buenos Aires

Novartis Investigative Site, Rosario, Santa Fe

Novartis Investigative Site, Buenos Aires, Not set

Novartis Investigative Site, Woolloongabba, Queensland

Novartis Investigative Site, Carlton, Victoria

Novartis Investigative Site, Melbourne, Victoria

Novartis Investigative Site, Alphaville Barueri, Sao Paulo

Novartis Investigative Site, Santo Andre, SP

Novartis Investigative Site, Sorocaba, SP

Novartis Investigative Site, Winnipeg, Manitoba

Novartis Investigative Site, Hamilton, Ontario

Novartis Investigative Site, Trois Rivieres, Quebec

Novartis Investigative Site, Fuzhou, Fujian

Novartis Investigative Site, Guangzhou, Guangdong

Novartis Investigative Site, Guangdong, Guangzhou

Novartis Investigative Site, Changsha, Hunan

Novartis Investigative Site, Wuxi, Jiangsu

Novartis Investigative Site, Chang Chun, Jilin

Novartis Investigative Site, Jinan, Shandong

Novartis Investigative Site, Chengdu, Sichuan

Novartis Investigative Site, Urumqi, Xinjiang

Novartis Investigative Site, Hangzhou, Zhejiang

Novartis Investigative Site, Yi Wu, Zhejiang

Novartis Investigative Site, Beijing, Not set

Novartis Investigative Site, Chongqing, Not set

Novartis Investigative Site, Jinan, Not set

Novartis Investigative Site, Nanjing, Not set

Novartis Investigative Site, Shanghai, Not set

Novartis Investigative Site, Tianjin, Not set

Novartis Investigative Site, Barranquilla, Atlantico

Novartis Investigative Site, Clermont Ferrand, Not set

Novartis Investigative Site, Grenoble, Not set

Novartis Investigative Site, Montpellier, Not set

Novartis Investigative Site, Nantes, Not set

Novartis Investigative Site, Paris, Not set

Novartis Investigative Site, Pierre Benite, Not set

Novartis Investigative Site, Rouen, Not set

Novartis Investigative Site, Toulouse, Not set

Novartis Investigative Site, Goettingen, Niedersachsen

Novartis Investigative Site, Berlin, Not set

Novartis Investigative Site, Dresden, Not set

Novartis Investigative Site, Luebeck, Not set

Novartis Investigative Site, Mainz, Not set

Novartis Investigative Site, Muenster, Not set

Novartis Investigative Site, Stade, Not set

Novartis Investigative Site, Tuebingen, Not set

Novartis Investigative Site, Hong Kong, Not set

Novartis Investigative Site, Debrecen, Hajdu Bihar

Novartis Investigative Site, Debrecen, Not set

Novartis Investigative Site, Szolnok, Not set

Novartis Investigative Site, Bangalore, Karnataka

Novartis Investigative Site, Mysore, Karnataka

Novartis Investigative Site, Nagpur, Maharashtra

Novartis Investigative Site, New Delhi, Not set

Novartis Investigative Site, Haifa, Not set

Novartis Investigative Site, Jerusalem, Not set

Novartis Investigative Site, Kfar Saba, Not set

Novartis Investigative Site, Ramat Gan, Not set

Novartis Investigative Site, Tel Aviv, Not set

Novartis Investigative Site, Ancona, AN

Novartis Investigative Site, Catania, CT

Novartis Investigative Site, Milano, MI

Novartis Investigative Site, Rozzano, MI

Novartis Investigative Site, Roma, RM

Novartis Investigative Site, Kitakyushu, Fukuoka

Novartis Investigative Site, Sapporo, Hokkaido

Novartis Investigative Site, Kamimashi-gun, Kumamoto

Novartis Investigative Site, Habikino city, Osaka

Novartis Investigative Site, Takatsuki, Osaka

Novartis Investigative Site, Ohtsu, Shiga

Novartis Investigative Site, Izumo-city, Shimane

Novartis Investigative Site, Shimotsuga Gun, Tochigi

Novartis Investigative Site, Bunkyo-ku, Tokyo

Novartis Investigative Site, Itabashi-ku, Tokyo

Novartis Investigative Site, Shinjuku Ku, Tokyo

Novartis Investigative Site, Tachikawa, Tokyo

Novartis Investigative Site, Hiroshima, Not set

Novartis Investigative Site, Kyoto, Not set

Novartis Investigative Site, Suwon si, Gyeonggi Do

Novartis Investigative Site, Seoul, Not set

Novartis Investigative Site, Muar, Johor

Novartis Investigative Site, Ipoh, Perak

Novartis Investigative Site, Georgetown, Pulau Pinang

Novartis Investigative Site, Kuala Lumpur, Wilayah Persekutuan

Novartis Investigative Site, Groningen, Not set

Novartis Investigative Site, Utrecht, Not set

Novartis Investigative Site, Bydgoszcz, Not set

Novartis Investigative Site, Olsztyn, Not set

Novartis Investigative Site, Rzeszow, Not set

Novartis Investigative Site, Warszawa, Not set

Novartis Investigative Site, Coimbra, Not set

Novartis Investigative Site, Lisboa, Not set

Novartis Investigative Site, Vila Nova De Gaia, Not set

Novartis Investigative Site, Bucharest, District 2

Novartis Investigative Site, Timisoara, Timis

Novartis Investigative Site, Brasov, Not set

Novartis Investigative Site, Cluj Napoca, Not set

Novartis Investigative Site, Singapore, Not set

Novartis Investigative Site, Bratislava, Not set

Novartis Investigative Site, Kezmarok, Not set

Novartis Investigative Site, Trnava, Not set

Novartis Investigative Site, Zilina, Not set

Novartis Investigative Site, Santiago de Compostela, A Coruna

Novartis Investigative Site, Granada, Andalucia

Novartis Investigative Site, Barcelona, Catalunya

Novartis Investigative Site, Mostoles, Madrid

Novartis Investigative Site, Alicante, Not set

Novartis Investigative Site, Cordoba, Not set

Novartis Investigative Site, Madrid, Not set

Novartis Investigative Site, Valencia, Not set

Novartis Investigative Site, Bangkok, Not set

Novartis Investigative Site, Chiang Mai, Not set

Novartis Investigative Site, Istanbul, Not set

Novartis Investigative Site, Sakarya, Not set

Novartis Investigative Site, Talas Kayseri, Not set

Novartis Investigative Site, Glasgow, Not set

Novartis Investigative Site, Oxford, Not set

Novartis Investigative Site, Hanoi, Not set

Novartis Investigative Site, Ho Chi Minh, Not set

Conditions: Chronic Inducible Urticaria

Learn More ›